Adage Capital Partners’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-5,500,000
| Closed | -$3.85M | – | 755 |
|
|
2018
Q4 | $3.85M | Hold |
5,500,000
| – | – | 0.01% | 630 |
|
|
2018
Q3 | $6.77M | Hold |
5,500,000
| – | – | 0.02% | 602 |
|
|
2018
Q2 | $6.11M | Hold |
5,500,000
| – | – | 0.01% | 637 |
|
|
2018
Q1 | $11.1M | Hold |
5,500,000
| – | – | 0.03% | 537 |
|
|
2017
Q4 | $6.6M | Buy |
5,500,000
+3,400,000
| +162% | +$4.08M | 0.01% | 608 |
|
|
2017
Q3 | $2.65M | Hold |
2,100,000
| – | – | 0.01% | 663 |
|
|
2017
Q2 | $2.79M | Buy |
2,100,000
+1,000,000
| +91% | +$1.33M | 0.01% | 656 |
|
|
2017
Q1 | $2.05M | Sell |
1,100,000
-1,000,000
| -48% | -$1.86M | 0.01% | 662 |
|
|
2016
Q4 | $10.9M | Hold |
2,100,000
| – | – | 0.03% | 517 |
|
|
2016
Q3 | $11.7M | Hold |
2,100,000
| – | – | 0.03% | 492 |
|
|
2016
Q2 | $11.7M | Buy |
2,100,000
+850,000
| +68% | +$4.72M | 0.03% | 483 |
|
|
2016
Q1 | $5.5M | Buy |
1,250,000
+350,000
| +39% | +$1.54M | 0.01% | 597 |
|
|
2015
Q4 | $5.42M | Buy |
+900,000
| New | +$5.42M | 0.01% | 595 |
|